Merck and Ridgeback Announce Japanese Government to Purchase 1.6 Million Courses of Molnupiravir, an Investigational Oral COVID-19 Antiviral Medicine, Upon Authorization or Approval Pharmaceutical Investing
Levitee Labs Signs Letter of Intent to Acquire a Chain of Specialty Addiction Pharmacies Located in British Columbia Psychedelics Investing
HempFusion Wellness Inc. To Report Third Quarter 2021 Earnings and Host Conference Call on Monday, November 15, 2021 Cannabis Investing News
Bristol Myers Squibb to Take Part in Wolfe Research Virtual Healthcare Conference Pharmaceutical Investing
Numinus to Host Extension of MAPS-Sponsored MDMA-Assisted Therapy for PTSD Trials Pharmaceutical Investing
Johnson & Johnson Endows Research!America Outstanding Achievement in Public Health Awards Pharmaceutical Investing
Asia Green Biotechnology Corp. Secures Financing to Proceed with Research Activities Technology Investing
Medtronic to announce financial results for its second quarter of fiscal year 2022 Medical Device Investing
